Endometriosis cost assessment (the EndoCost study): a cost-of-illness study protocol

Simoens S, Steven Simoens, Lone Hummelshoj, Lone Hummelshøj, Gerard Dunselman, Dunselman G, Gerard A.J. Dunselman, Iris Brandes, Carmen D. Dirksen, Carmen Dirksen, Dirksen C, D'Hooghe T, Thomas D'Hooghe, Thomas D’Hooghe, EndoCost Consortium
Gynecologic and obstetric investigation · 2010 · vol. 71(3) , pp. 170–176 · doi:10.1159/000316055 · PMID:21160141 · W2076562680
Other OA: closed CC0 ⤵ 77 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-06 ⓘ

The EndoCost study protocol outlines a multicenter, prevalence-based cost-of-illness analysis to determine the societal costs of endometriosis across 10 countries, measuring direct and indirect expenses and quality of life.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

AIMS: The EndoCost study aims to calculate the costs of endometriosis from a societal perspective. METHODS: This multicentre, prevalence-based cost-of-illness analysis aggregates data on endometriosis costs and quality of life from a prospective hospital questionnaire and from both retrospective and prospective patient questionnaires. The EndoCost study comprises 12 representative tertiary care centres involved in the care of women with endometriosis in 10 countries. The sample includes patients with a laparoscopic and/or histological diagnosis of endometriosis and with at least 1 patient contact related to endometriosis during 2008. The EndoCost study measures direct healthcare costs (e.g. costs of medication, physician visits), direct non-healthcare costs (e.g. transportation costs), and indirect costs of productivity loss. Cost questions are developed specifically for the purpose of the EndoCost study. Quality of life is measured using the EuroQol-5D and relevant parts of the Global Study of Women's Health instruments. Both aggregate analyses and country-specific analyses are planned for total costs per patient. Costs are broken down into cost drivers and into the various payers that incur costs. CONCLUSIONS: The cost estimates provided by the EndoCost cost-of-illness analysis may be used to justify the prioritisation of future research in endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

MeSH descriptors

Cost of Illness Cost of Illness Endometriosis Health Care Costs Health Care Costs Endometriosis Endometriosis Female Female Health Care Surveys Health Care Surveys Humans Humans Prospective Studies Prospective Studies Quality of Life Quality of Life Retrospective Studies Retrospective Studies Surveys and Questionnaires

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

References (19)

Cited by (50)

Source provenance

europepmc
last seen: 2026-10-17T06:09:56.316927+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:08:21.741906+00:00
unpaywall
last seen: 2026-10-17T06:24:38.187582+00:00
License: CC0 · commercial use OK